V
Vivani Medical, Inc. (VANI)
NCM – Real Time Price. Currency in USD
1.20
+0.06 (5.26%)
At close: Jun 26, 2026, 4:00 PM EDT
1.19
-0.01 (-0.83%)
After-hours: Jun 26, 2026, 4:39 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.20
+0.06 (5.26%)
At close: Jun 26, 2026, 4:00 PM EDT
1.19
-0.01 (-0.83%)
After-hours: Jun 26, 2026, 4:39 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $19.7M significantly exceed its total debt $18.4M, ensuring strong financial flexibility
Total current assets $21.5M exceed Total current liabilities $6.8M, highlighting excellent liquidity
Debt-to-equity ratio (1.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$6.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.18 | 6.05 | 10 | |
| Quick ratio | 3.18 | 5.63 | 10 | |
| Debt to Equity | 0.96 | 0.30 | 6.0 | |
| Debt to Assets | 0.43 | 1.04 | 5.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -381K | -357K | -400K | -424K | -452K |
| Operating Income | -21M | -27M | -25M | -28M | -28M |
| Net Income | -14M | -26M | -23M | -27M | -27M |
| EBITDA | -20M | -27M | -24M | -27M | -27M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 29.17 | 5.5 |
| Next quarter | N/A | 27.27 | 5.5 |
| Current year | N/A | 23.26 | 5.5 |
| Next year | N/A | -21.21 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -2.21 | 11.11 | 11.35 | 6.3 |
| Y/Y | 999 | -7.57 | 27.27 | -19.94 | 5.5 |
| 3y average | 999 | -29.83 | -8.28 | -11.59 | 3.3 |
| 5y average | 999 | -16.81 | -8.28 | -13.58 | 3.3 |
| Weighted average score | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |